Valeant shares plunge to 2-year low as U.S. launches new drug price probe

Valeant shares fell to their lowest level in more than two years on Thursday as Republican and Democratic Senators announced a new probe into pricing policies at drug companies.

Source:CBC | Business News http://ift.tt/1RY56pq